Home » Authors » Trista Morrison

Articles by Trista Morrison

NewCo News: Sanaria Nears Clinic with Live Attenuated Malaria Vaccine

Jan. 29, 2008

By Trista Morrison

Amgen Earnings Beat Estimates, But ESA Uncertainty Looms

Jan. 28, 2008

By Trista Morrison

Despite regulatory and reimbursement challenges to its erythropoietin stimulating agent (ESA) franchise, Amgen Inc. beat analyst estimates for earnings in the fourth quarter of 2007. (BioWorld Today)

Amgen Earnings Beat Estimates, But ESA Uncertainty Looms

Jan. 28, 2008

By Trista Morrison

Despite regulatory and reimbursement challenges to its erythropoietin stimulating agent (ESA) franchise, Amgen Inc. beat analyst estimates for earnings in the fourth quarter of 2007. (BioWorld Today)

Orexigen Prices $77M Follow-On as Obesity Trials Move Ahead

Jan. 25, 2008

By Trista Morrison

Orexigen Prices $77M Follow-On as Obesity Trials Move Ahead

Jan. 25, 2008

By Trista Morrison

Adverse Events in Albuferon Trials Devastate HGS Shares

Jan. 24, 2008

By Trista Morrison

Adverse Events in Albuferon Trials Devastate HGS Shares

Jan. 24, 2008

By Trista Morrison

KV Pharma Buys Gestiva from Hologic for $82M Cash

Jan. 23, 2008

By Trista Morrison

KV Pharma Buys Gestiva from Hologic for $82M Cash

Jan. 23, 2008

By Trista Morrison

The Myths and Realities of Corporate Venture Capital

Jan. 22, 2008

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...